Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Harvard Bioscience Inc (NASDAQ: HBIO) closed the day trading at $0.41 down -0.99% from the previous closing price of $0.41. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 2.14 million shares were traded.
Ratios:
For a better understanding of HBIO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.58. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 0.49.
On March 10, 2023, The Benchmark Company Upgraded its rating to Buy which previously was Speculative Buy and also upped its target price recommendation from $3 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’24 when Green James W bought 10,000 shares for $2.91 per share. The transaction valued at 29,100 led to the insider holds 3,111,091 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20 while its Price-to-Book (P/B) ratio in mrq is 1.22.
Stock Price History:
Over the past 52 weeks, HBIO has reached a high of $3.60, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 2.52%, while the 200-Day Moving Average is calculated to be -74.75%.
Shares Statistics:
A total of 44.21M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 15.39% of the company’s shares, while institutions hold 58.64% stake in the company.
